Síndrome metabólico en funcionarios del Hospital Regional de Encarnación
DOI:
https://doi.org/10.70833/rseisa4item25Keywords:
metabolic syndrome, national education program on cholesterol, diabetes mellitus, hypertension, obesity, hypertriglyceridemiaAbstract
Background: Metabolic syndrome is a set of risk factors that can lead to acute coronary syndrome, is considered as a driver of the epidemic of cardiovascular disease. The aim of this study is to determine the prevalence of metabolic syndrome in Regional Hospital officials from Encarnación, defined by ATP III.
Methods: observational, cross-sectional, we studied 100 HRE officials, regardless of rank, of both genders, aged between 20 to 65.
Results: The majority of the population were woman aged 20-30. 7 people were pre-diabetic and 4 suffered from type 2 DM. The prevalence of dyslipidemia was higher, affecting 22 patients, half of the population had decreased HDL, and 28 people had hypertriglyceridemia. Twenty-two people had pre-hypertension, stage I hypertension 4 and 4 stage II hypertension. The majority showed weight gain, including overweight compared dominated obesity which is presented in smaller numbers. In 20 males the abdominal circumference was = 102 cm and 43 women AC was = 88 cm. 15 men and 21 women had metabolic syndrome.
Downloads
References
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2492.
American College of Endocrinology Task Force on the Insulin Resistance Syndrome: American College of Endocrinology Position Statement on the Insulin Resistance Syndrome.. Endocr Pract 2003;9:236-252.
Alexander CM, Landsman PB, Teutsch SM, Haffner SM, for the Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NECP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants aged 50 years and older. Diabetes. 2003;52:1210-4.
International Diabetes Federation (IDF). Worldwide definition of Metabolic Syndrome. RevPanam Salud Pública 2005; 18: 665-9.
Solymoss BC, Bourassa MG, Marcil M, Levesque S, Varga S, Campeau L. Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronaryangiographic alterations. Coronary Artery
Dis 2009;20:1-8.
Ayala M. Manual de normas: guías para el control de la Hipertensión Arterial. Asunción: Ministerio de Salud Pública y Bienestar Social e Instituto Nacional de Prevención Cardiovascular, 2004
Schner Chávez M, Izquierdo J, Sole J, Tarazona A, Pinzón JB, Rios M. Prevalence of the metabolic syndrome in a rural and urban population in Colombia. Diab Res Clin Pract 2002; 57(1):530-2.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome Among US adults: Findings from the third national health and nutrition examination survey. JAMA 2002; 16(287):356-9.
Jimenez JT, Palacios M, Canete F, Barriocanal LA, Medina U, Figueredo R, et al. Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay. Diabet ed. 1998; 15(4):334-8.
Álvarez E, Ribas L, Serra Ll.Prevalencia del síndrome metabólico en la población de la comunidad Canaria. Med Clin (Barc) 2003;120(5):172-4.
Rodriguez A, Sanchez M, Martinez L, Síndrome Metabólico.2002. Disponible en: http://bvs.sld.cu/revistas/end/vol13_3_02/end08302.pdf.
Maiz A, síndrome metabólico. 2005. Disponible en : http://escuela.med.puc.cl/publ/boletin/20051/articulo4.pdf
Ridket PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-2825.
Muñoz M.T, síndrome metabólico. 2007. Disponible en: http://www.sepeap.org/imagenes/secciones/Image/_USER_/Sindrome_metabolico.pdf.
Carbajal H, Salazar M, Sindrome metabólico: aspectos clínicos. Tratamiento. 2007. Disponible en: http://www.fac.org.ar/1/publicaciones/libros/tratfac/hta_01/metabolico.pdf.
Lopez M, Sosa M, Labrousse N, síndrome metabólico, 2007. Disponible en: http://www.med.unne.edu.ar/revista/revista174/3_174.pdf.
Esper R, Sanchez M, Elizondo S, síndrome metabolico, 2007.Disponible en: http://www.ejournal.unam.mx/rfm/no49-3/RFM49305.pdf.
Pineda C, síndrome metabólico, 2008 Enero, Disponible en: http://colombiamedica.univalle.edu.co/Vol39No1/htmlv39n1/v39n1a13.pdf.
Emma Hitt. Thiazolidinediones and Sulfonylureas Most Effective in Lowering HbA1C.2010 Jun.Disponible en : http://cme.medscape.com/viewarticle.
Alegria E, Castellano J, Alegria A, Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapeutica, 2008 0ct, Disponible en : http://www.revespcardiol.org/cardio/ctl_servlet?.
Dennis L. Kasper, Eugene Braunwald, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, y Kurt J. Isselbacher, editores. Harrison´s Principios de Medicina Interna. . Parte VIII, Enfermedades Cardiovasculares, sección 4, Enfermedades vasculares, Cap 225, Prevención y Tratamiento de la Aterosclerosis.16ta ed. España: Mac Graw Hill Interamericana; 2006.
Obesidad. Disponible en: http://www.seh-lelha.org/club/cuestion29.htm ; obtenido el: 30 de diciembre del 2006.
Síndrome Metabólico; disponible en: http://www.monografias.com/trabajos28/sindrome-metabolico/sindrome-metabolico.shtml ; obtenido el: 31 de diciembre del 2006.
Madrid-Miller A, Alcaraz-Ruiz A, Borrayo-Sánchez G, Almeida-Gutiérrez E, Vargas-Guzmán R, Jáuregui-Aguilar R. Síndrome metabólico, impacto clínico y angiográfico en pacientes con síndrome coronario agudo. 2010 marzo-abril, http://www.nietoeditores.com.mx/download/Cirugia%20y%20Cirujanos/ marzoabril2010/Cir%20Cir%202.7%20SINDROME%20ME-TABOLICO.pdf
Downloads
Published
How to Cite
License
Creative Commons Attribution License CC-BY
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, including commercially.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if any changes have been made. You may do so in any reasonable way, but not in any way that suggests that you or your use is endorsed by the Licensor.
